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unclear, several suggestions have been proposed such as 
premature resumption of meiosis results in aged oocytes and 
alterations in the steroid environment of the antrum. In this 
study, pituitary suppressed patients undergoing IVF treatment 
were exposed to differing concentrations of LH, and the effects 
on oocyte maturation and fertilization were evaluated. 
Materials and methods: A randomized prospective assessor-
blind group comparative study was performed. Couples under-
going their first IVF treatment cycle were recruited to the 
study. Pituitary down-regulation was achieved using the long 
protocol GnRH analogue regime prior to randomization to one 
of four gonadotrophin preparations. The amount of FSH was 
kept constant at 75 IU/ampoule, while the LH dose in the 
gonadotrophin preparations varied (0,1,25 and 75 IU/ampoule; 
group A, FSHlLH 75:0; group B, FSHlLH 75:1; group C, 
FSHILH 75:25; group D, FSHlLH 75:75. Gonadotrophin 
preparations were controlled for batch variation. 
Results: Group A showed a significantly lower percentage of 
mature and fertilized oocytes and a correspondingly higher 
percentage of immature and unfertilized oocytes. The frequen-
cies of atretic and abnormally fertilized oocytes were too small 
for any valid comparison to be made. 
Total fertilization failure by group 
Group 
A 
(75:0)a 
No. of cases failed to fertilize 6 (17.6) 
No. of cases fertilized 28 (82.4) 
Total (n = 128) 34 
B 
(75:1)a 
3 (13.0) 
20 (87.0) 
23 
C 
(75:25)a 
3 (11.1) 
24 (88.9) 
27 
D 
(75:75)a 
0(0) 
26 (100) 
26 
Kruskal-Wallis exact test, P = 0.03. Values in parentheses are percentages. 
aFSH:LH doses. 
Conclusion: A dose-related trend in total fertilization failure 
was observed, with group A, containing no LH, showing the 
highest rate of total fertilization failure. 
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Introduction: Our objective was to study the role of inhibinl 
activin in early embryo development. To do this, the expression 
of inhibinlactivin subunits, activin receptors (types I and II) 
and follistatin in human granulosa luteal cells, endometrial 
stromal cells and preimplantation embryos was assessed to 
evaluate the possibility of interactions between the embryo 
and the endometrium. 
Materials and methods: Transcripts of inhibinlactivin sub-
units, activin receptors and follistatin were detected by a 
reverse-transcriptase PCR in human granulosa luteal cells, 
endometrial stromal cells treated with or without progesterone 
and preimplantation embryos. 
Results: 
Cel1 numbers (n) of the embryo samples studied and their gene expressions (+1-) 
a~subunit ~A-subunit i3B-subunit Activin I Activin II Follistatin 
receptor receptor 
4- to 6-cell pre-embryo 
-(7) - (5) - (5) - (5) + (6) - (5) 
7 -cell to morula pre-embryo - (4) - (4) - (4) + (4) + (4) + (4) 
Blastocyst - (4) + (4) - (4) + (4) + (4) + (4) 
Granulosa luteal cells + (2) + (2) + (2) + (2) + (2) + (2) 
Endometrial stromal cells - (10) + (10) - (10) + (10) + (10) + (10) 
Progesterone-treated - (2) + (2) - (2) + (2) + (2) + (2) 
endometrial stromal cells 
Conclusions: Transcripts of inhibinlactivin subunits were 
detected in granulosa luteal cells. Inhibinlactivin subunits were 
not found in preimplantation embryos, but activin A mRNA 
was found at the blastocyst stage. Only activin A transcripts 
were detected in endometrial stromal cells treated with or 
without progesterone. Activin receptors (types I and II) were 
detected in all embryos and cells studied. This may suggest 
that activin, not inhibin, plays an important role in early 
embryo development. We postulate that embry~ndometrium 
interactions may occur via activin produced by endometrial 
stromal cells and preimplantation embryo receptors. 
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Introduction: To develop an HCG-independent early preg-
nancy test to be used in IVF cycles under luteal support with 
HCG, we developed a highly sensitive microplate enzyme 
immunoassay method for pregnancy-specific ~1-glycoprotein 
(SPI), a monomeric glycoprotein of syncytiotrophoblastic 
origin. We observed that, even in the presence of such 
exogenous support, HCG was superior to SPI. However, we 
also observed, in selected patients only, the presence of small 
amounts of serum SPI around the time of oocyte retrieval 
(OPU) and embryo transfer, which seemed to be associated 
with a bad pregnancy prognosis. The aim of this study was 
to test this hypothesis and to investigate the role of such 
'ectopic' SPl. 
Materials and methods: A total of 97 consecutive cycles of 
conventional IVF, without male infertility and with uncomplic-
ated embryo transfer, distributed among 75 women, were 
studied. The 'long' protocol of agonist down-regulation and 
ovarian stimulation with menopausal gonadotrophins was used. 
Serum was obtained on at least two occasions between days 
OPU-3 and OPU +2 (Le. day of embryo transfer). SPI was 
determined with a sensitivity of 0.05 ng/ml. On day OPU-2 
endometrial thickness was measured by ultrasound and serum 
steroid hormone concentrations determined. Pregnancy was 
diagnosed by HCG on day ET + 15-17, and confirmed by 
ultrasound 2-3 weeks thereafter. 
Results: The cycles were divided into group A (no detectable 
serum SPI at any time between OPU-3 and embryo transfer) 
and group B (presenting at least one SPI reading >0.1 ng/ 
ml). Amongst the 72 cycles not leading to pregnancy, 27 
(38%) fell into group B; in the 25 pregnancy cycles only two 
were classified as group B (8%). In all, 22 unsuccessful women 
underwent a second attempt: of 12 group A patients, six (50%) 
became pregnant, while no pregnancy was achieved in the 
remaining 10 group B patients. Moreover, nine of these 10 
women presented a repeat group B pattern, while one was 
group A (no SPl). All six previously group A, second-attempt 
non-pregnant women were a repeat group A. Endometrial 
thickness was negatively correlated with SPI before embryo 
transfer (P = 0.0115). However, no difference in day OPU-2 
endometrial thickness was observed between group A non-
pregnant and subsequently pregnant patients. 
Conclusion: The occurrence of serum SPI concentrations on 
or before the day of embryo transfer >0.1 ng/ml and in 
combination with a slightly reduced endometrial thickness is 
associated with a poor IVF pregnancy prognosis not only in 
the current but also in subsequent treatment cycles. Further 
studies will focus on the identification of factors responsible 
for SPI secretion by an as yet unknown source and, because 
patients tend to remain in either group A or B, on treatment 
lines for changing group B patients to group A, thus obtaining 
a better prognosis in subsequent attempts. 
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Introduction: Normal pregnancy is an immunological paradox 
because the embryo, a semi-allograft, manages to evade 
rejection by the maternal immune system during its intrauterine 
life. In contrast, recurrent miscarriage (RM) patients experience 
rejection (miscarriage) in early pregnancy. The maternal allo-
graft immune response comprises a T helper I (TH1) cell-
mediated cytotoxic rejection immunity and a THz-mediated B 
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cell humoral immunity. Cytokines are of pivotal importance 
in the mediation ofTHI and TH2 immunity. Normal pregnancy 
is associated with a cytokine-induced modulation of predomin-
ant TH2 immunity, whereas idiopathic RM may involve an 
increased systemic THI but a decreased TH2 immunity. To 
evaluate further the hypothesis of cytokines and THI and TH2 
immunity in human reproduction, we studied the pattern of 
cytokine expression in the peri-implantation endometrium of 
RM patients and compared it with that in normal, fertile women. 
Materials and methods: A total of 11 RM patients (having 
three or more consecutive first trimester miscarriages) and 10 
fertile women with previously successful pregnancies were 
recruited to the study. Endometrial pipelle sample collection 
was timed to the mid-cycle ovulatory LH surge using serum 
or urine LH monitoring. All samples were collected during 
the peri-implantation period LH + 7-LH + 10 and stored in 
liquid nitrogen until analysed. The samples were processed by 
reverse transcriptase-PCR after messenger ribonucleic acid 
extraction to identify the presence of the THI cytokines IL-2 
and interferon-y (IFN-y), and the TH2 cytokine IL-6. 
Results: The THI cytokine IL-2 was expressed in 10 out of 
11 of the RM patients compared with one out of 10 of the 
controls (P = 0.001), whereas IFN-y is expressed in eight out 
of 11 of the RM patients compared with two out of 10 of the 
controls (P = 0.047). The TH2 cytokine IL-6 is expressed in 
two out of 11 of the RM patients compared with eight out of 
10 of the controls (P = 0.017). 
Conclusion: To our knowledge, this is the first study to 
demonstrate a predominant THI and a lack of TH2 immune 
response in the peri-implantation endometrium of RM patients 
compared with normal fertile women. We hypothesize that 
successful implantation and maintenance of a normal pregnancy 
are dependent on the type of maternal immunity present in 
peri-implantation endometrium, derangements of which may 
result in RM. A predominantly THI and a lack of TH2 
immunity may result in pregnancy rejection, whereas the 
converse may be conducive to maintaining pregnancy. In 
future, attempts at cytokine-induced immunomodulation may 
be used to treat RM, as have been tried successfully in animals. 
In addition, cytokine-induced immunomodulation may improve 
implantation rates in assisted conception treatments and has 
potential as a reversible immune contraceptive. 
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0-116. Antiprogestin action in primate endometrium: are 
glandular and stromal effects mediated by the 
progesterone receptor? 
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Introduction: Besides being an antiprogestin, mifepristone 
(RU 486) was recently shown to antagonize oestrogen-
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